Myoderm is granted a Wholesale Drug License to buy, sell and distribute pharmaceuticals within England
Norristown, PA – March 7, 2011, Myoderm, a leading global supplier of commercial drugs for clinical research and clinical trials, today announced that they have been granted a Wholesale Dealer License from the Medicines and Healthcare products Regulatory Agency (MHRA). In addition, Myoderm has established a new partnership with a leading European Pharmaceutical logistics provider.
The license agreement granted by the MHRA enables Myoderm to buy, sell and distribute pharmaceuticals within the UK. Providing more direct access to drug manufacturers across Europe, the Wholesale Dealer License will facilitate Myoderm’s current supply capabilities and business objectives of commercial expansion and strategic positioning within the European Pharmaceutical Market.
“Acquiring our Wholesale Dealer License and partnering with a leading European, Pharmaceutical logistics provider is critical to our continued effort to enhance our worldwide supply capabilities,” says Mike Cohen, Myoderm’s Managing Director. Along with the MHRA license agreement, Myoderm’s newest partnership will allow them to offer receiving, inspection, warehousing and distribution of pharmaceutical products. These services will allow Myoderm to have complete control over materials procured and distributed throughout Europe.
About Myoderm
With a proven track record of supply and distribution of pharmaceuticals to depots, clinical trial sites, sponsor companies and clinical packagers around the globe, Myoderm has evolved into a leader within the Clinical Trial Drug Supply industry for over 20 years. Myoderm is confident in its capabilities to continue to expand and strengthen its international relationships. For more information on Myoderm, contact Lorann Morse at +1.610.233.3304 or sales@myoderm.com.
